Published in Brain on August 01, 1989
In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol (1990) 2.70
Screening for prolonged incubation of HTLV-I infection in British and Jamaican relatives of British patients with tropical spastic paraparesis. BMJ (1990) 1.45
Multiple sclerosis, tropical spastic paraparesis and HTLV-1 infection in Afro-Caribbean patients in the United Kingdom. J Neurol Neurosurg Psychiatry (1991) 1.16
Use of dried blood spots for the detection and confirmation of HTLV-I specific antibodies for epidemiological purposes. J Clin Pathol (1995) 1.13
Infiltration of helper/inducer T lymphocytes heralds central nervous system damage in human T-cell leukemia virus infection. Am J Pathol (1992) 1.11
Dendritic cells infected in vitro with human T cell leukaemia/lymphoma virus type-1 (HTLV-1); enhanced lymphocytic proliferation and tropical spastic paraparesis. Clin Exp Immunol (1993) 1.08
Tropical spastic paraparesis and human T-cell lymphotropic virus type 1. J Neurol Neurosurg Psychiatry (1990) 0.88
HTLV-I infection and neurological disease in Rio de Janeiro. J Neurol Neurosurg Psychiatry (1992) 0.87
Mechanism of abdominal massage for difficult defecation in a patient with myelopathy (HAM/TSP). J Neurol (2005) 0.84
Intermittent high-dose vitamin C therapy in patients with HTLV-I associated myelopathy. J Neurol Neurosurg Psychiatry (1993) 0.84
HTLV-1 infection: the clinical spectrum widens. J Neurol Neurosurg Psychiatry (1991) 0.79
MRI of thoracic cord in tropical spastic paraparesis. J Neurol Neurosurg Psychiatry (1990) 0.78
Does a retrovirally encoded superantigen cause multiple sclerosis? J Neurol Neurosurg Psychiatry (1991) 0.77
Neuropathological studies of the spinal cord in early stage HTLV-I-associated myelopathy (HAM). J Neurol Neurosurg Psychiatry (1993) 0.77
An autopsy case of human T lymphotropic virus type I-associated myelopathy (HAM) with a duration of 28 years. Acta Neuropathol (1990) 0.76
MRI-pathological correlate of brain lesions in a necropsy case of HTLV-I associated myelopathy. J Neurol Neurosurg Psychiatry (1993) 0.75
Myelopathy associated with human T cell lymphotropic virus type 1 in a white European native to England. BMJ (1992) 0.75
Chronic inflammatory demyelinating polyneuropathy in a patient infected with human T lymphotropic virus type I. BMJ Case Rep (2009) 0.75
Methylprednisolone therapy in tropical spastic paraparesis. J Neurol Neurosurg Psychiatry (1990) 0.75
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (1985) 30.47
The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell (1986) 22.26
A Fear-Avoidance Beliefs Questionnaire (FABQ) and the role of fear-avoidance beliefs in chronic low back pain and disability. Pain (1993) 9.57
Neutralization of human T-lymphotropic virus type III by sera of AIDS and AIDS-risk patients. Nature (1985) 6.65
Variable and conserved neutralization antigens of human immunodeficiency virus. Nature (1987) 5.29
Hydroxyproline arabinosides in the plant kingdom. Plant Physiol (1971) 4.67
Epitopes of the CD4 antigen and HIV infection. Science (1986) 4.50
Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis. Lancet (1997) 4.43
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology (2006) 4.38
Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis. Neurology (2011) 4.25
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain (1997) 3.87
Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature (1989) 3.54
Phase I study of an immunomodulatory thalidomide analog, CC-4047, in relapsed or refractory multiple myeloma. J Clin Oncol (2004) 3.37
Genetic heterogeneity and mitochondrial DNA heteroplasmy in Leber's hereditary optic neuropathy. J Med Genet (1989) 3.25
The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions. A quantitative study. Brain (1987) 3.15
Central nervous system sarcoidosis--diagnosis and management. QJM (1999) 3.11
HIV infection does not require endocytosis of its receptor, CD4. Cell (1988) 2.88
The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain (2000) 2.84
Expression of T3 in association with a molecule distinct from the T-cell antigen receptor heterodimer. Proc Natl Acad Sci U S A (1986) 2.73
In vivo cellular tropism of human T-cell leukemia virus type 1. J Virol (1990) 2.70
Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain (2008) 2.67
The stochastic nature of larval connectivity among nearshore marine populations. Proc Natl Acad Sci U S A (2008) 2.65
Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol (1984) 2.64
Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain (1992) 2.62
Failure of 3,4-diaminopyridine to reverse conduction block in inflammatory demyelinating neuropathies. Ann Neurol (1993) 2.56
Diffusion tensor imaging of lesions and normal-appearing white matter in multiple sclerosis. Neurology (1999) 2.54
Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain (1996) 2.54
Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain (1990) 2.53
Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol (1985) 2.50
Physicians' charges under Medicare: assignment rates and beneficiary liability. Health Care Financ Rev (1980) 2.50
Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI. Neurology (2000) 2.47
Diffusion tensor imaging can detect and quantify corticospinal tract degeneration after stroke. J Neurol Neurosurg Psychiatry (2000) 2.44
The persistent vegetative state. BMJ (1995) 2.35
Management of acute optic neuritis. Lancet (2002) 2.33
Primary structure of Torpedo californica acetylcholinesterase deduced from its cDNA sequence. Nature (1986) 2.32
Superficial siderosis of the central nervous system. Brain (1995) 2.31
Human immunodeficiency virus infection of monocytic and T-lymphocytic cells: receptor modulation and differentiation induced by phorbol ester. Virology (1987) 2.30
Parathyroid venous sampling: anatomic considerations and results in 95 patients with primary hyperparathyroidism. Br J Radiol (1980) 2.29
Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain (1988) 2.29
Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer (2001) 2.26
Estimating individual contributions to population growth: evolutionary fitness in ecological time. Proc Biol Sci (2006) 2.25
Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol (1991) 2.25
Objective clinical evaluation of physical impairment in chronic low back pain. Spine (Phila Pa 1976) (1992) 2.23
AIDS pathogenesis: HIV envelope and its interaction with cell proteins. Immunol Today (1990) 2.21
Paradoxical expansion of intracranial tuberculomas during chemotherapy. Lancet (1984) 2.19
An analysis of the break points of structural rearrangements in man. J Med Genet (1974) 2.18
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL. Neurology (2007) 2.17
Serum insulin-like growth factor-1 is not a useful marker of prostate cancer. BJU Int (1999) 2.14
Hydroxyproline heterooligosaccharides in Chlamydomonas. Science (1972) 2.12
Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy. Neurology (2008) 2.11
Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology (2008) 2.06
PAX6 haploinsufficiency causes cerebral malformation and olfactory dysfunction in humans. Nat Genet (2001) 2.05
Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects. Br J Cancer (2002) 2.03
Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry (1996) 2.02
Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain (2002) 2.01
Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis. Brain (1990) 2.00
Striking a balance between biodiversity conservation and socioeconomic viability in the design of marine protected areas. Conserv Biol (2008) 1.99
Patterns of disease activity in multiple sclerosis: clinical and magnetic resonance imaging study. BMJ (1990) 1.99
The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up. Brain (1998) 1.99
The chemical composition of the cell wall of Chlamydomonas gymnogama and the concept of a plant cell wall protein. J Cell Biol (1974) 1.95
Magnetic resonance imaging in isolated noncompressive spinal cord syndromes. Ann Neurol (1987) 1.93
Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology (2009) 1.93
Antibody to human T-lymphotropic virus type 1 in West-Indian-born UK residents with spastic paraparesis. Lancet (1987) 1.92
MRI criteria for MS in patients with clinically isolated syndromes. Neurology (2010) 1.90
Spinal epidural angiomatous malformations draining into intrathecal veins. Neuroradiology (1977) 1.88
Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology (1993) 1.87
Habitat structure and population persistence in an experimental community. Nature (2001) 1.86
Proton magnetic resonance spectroscopy of an acute and chronic lesion in multiple sclerosis. Lancet (1991) 1.86
The pathophysiology of spinal vascular malformations. J Neurol Sci (1974) 1.85
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group. Neurology (1999) 1.82
Neuropathological abnormalities of the corpus callosum in schizophrenia: a diffusion tensor imaging study. J Neurol Neurosurg Psychiatry (2000) 1.81
Sample sizes for brain atrophy outcomes in trials for secondary progressive multiple sclerosis. Neurology (2008) 1.80
Mitochondrial encephalomyopathies: biochemical studies in two cases revealing defects in the respiratory chain. Brain (1982) 1.80
Primary progressive multiple sclerosis. Brain (1997) 1.80
Precise estimate of fundamental in-vivo MT parameters in human brain in clinically feasible times. Magn Reson Imaging (2002) 1.80
Does computed tomography have a role in the evaluation of complicated acute bacterial meningitis in childhood? Dev Med Child Neurol (1992) 1.79
Human T cell leukaemia/lymphoma virus and blood donation. BMJ (1993) 1.79
Sleep deprivation increases cortical excitability in epilepsy: syndrome-specific effects. Neurology (2006) 1.77
Pain relief with oral cannabinoids in familial Mediterranean fever. Anaesthesia (1997) 1.77
A multicenter measurement of magnetization transfer ratio in normal white matter. J Magn Reson Imaging (1999) 1.76
Single-species models for many-species food webs. Nature (2002) 1.72
Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain (1996) 1.69
Neurological complications in Behçet's syndrome. Brain (1999) 1.68
Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain (1994) 1.68
Treatment of periodic alternating nystagmus. Ann Neurol (1980) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol (2000) 1.66
Interferon beta-1b. Lancet (1994) 1.64